Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information

Stat News

1 December 2022 - At a time when many Americans are clamouring for more transparency into prescription drug pricing, one key provider of that data is making it harder to access the information.

A new venture called Merative - which was formed recently from the ashes of IBM's Watson health division - has decided it will nom longer provide the media with pricing changes for specific medicines.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Transparency , Data